Home » FDA » Page 25

Tag Archives: FDA

Antibiotics with QIDP Designation – – – Updated 9-30-14

Posted on by — 2 Comments ↓

For the latest QIDP listing, please click HERE   Since FDA issued the QIDP designation in 2012, many companies have requested this important ‘label’.  Which should not come as a surprise: QIDP status confers significant benefits – and there is no downside. While an official FDA list of drugs that have Continue reading Antibiotics with QIDP Designation – – – Updated 9-30-14→

FDA Adboard on Tedizolid – Why?

Posted on by — No Comments ↓

FDA’s Advisory Board session for tedizolid (3/31/2014) was a foregone affair:  Looking at the reviewer’s slides, there was really no question about the drug’s efficacy.  Did tedizolid cure as many patients as linezolid?  Yes, it did.  Did the sponsor follow the latest ABSSSI Guidance criteria for establishing non-inferiority?  Yes, they Continue reading FDA Adboard on Tedizolid – Why?→